Edwards Lifesciences EW has announced one-year, real-world data on its SAPIEN 3 Ultra RESILIA valve at the PCR London Valves 2024.These data add to the extensive body of evidence on the company ...

Edwards Lifesciences reports strong contributions from all product groups ??? TAVR, TTMT and surgical structural heart ??? in ...

In a study of real-world evidence from the TVT Registry, researchers compared the outcomes of more than 10,000 patients treated with the SAPIEN 3 Ultra RESILIA valve to those receiving SAPIEN 3 ...